Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The company’s shares closed yesterday at $134.36.

Cardinal Health (CAH) closed at $133.69 in the latest trading session, marking a +1.92% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 2.51%. Elsewhere ...

There would be no better way for the church to demonstrate its commitment to racial inclusivity than by naming a Black pope. It would make a profound statement — not ... level of the Catholic faith ...

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.

In November, Cardinal Health acquired a majority stake in GI Alliance for $2.8 billion, one of the largest transactions in the gastroenterology space in recent years. Here are five key takeaways from ...

Cardinal Health has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development for the company, particularly in the U.S. market. Over the last quarter ...